Intro to the Series An estimated 1 in 10,000 people are born with hemophilia, a blood disorder caused by a lack of proteins needed to stop bleeding. While those in developed countries have access to treatment that allows them to lead normal lives, that is not the case for…

Emotional testimony from witnesses marked the beginning of a public inquiry yesterday into a contaminated blood scandal in the UK.   Before screening of blood products became common in the early 1990s, about 5,000 people with hemophilia and other bleeding disorders were…

Americans living with hemophilia (mostly men, as the genetic condition affects the X chromosome) have to live with care, prioritizing their safety and ability to pay for costly medical support. A single fall or bump can lead to a life-threatening bleed and medical bills can…

CUGH, NPR’s Goats and Soda Blog, and Global Health NOW of the Johns Hopkins Bloomberg School of Global Health selected two winning entries from over 150 thought-provoking entries. It’s the fourth year of our annual competition, which seeks to identify and give a platform to…

An experimental gene therapy could change the lives of those living with hemophilia A, an incredibly high-maintenance bleeding disorder that requires frequent injections.